Loading company…
Skeletalis develops targeted therapies for osteoporosis and other bone conditions.
Founded in 2025 and based in Boston, Skeletalis develops treatments for musculoskeletal conditions, including osteoporosis. Its OASIS platform uses a targeted small-molecule approach to address active bone loss. In November 2025, it raised USD 8.00 mn led by Pillar, with participation from KdT Ventures, Age1 and Slocum Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in